Global Hypodermic Needles Market is expected to reach $ 5.4 billion by 2027Global Hypodermic Needles Market is valued approximately at $3.35 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2021-2027. A hypodermic needle refers to a hollow needle generally used for medical applications including vaccination, blood sample collection, drug delivery etc. Growing focus on the prevention of needle-stick injuries coupled with strict regulations regarding the use of safety needles is fueling the market growth. Also, growing number of vaccine drives, especially since the advent of COVID-19, has contributed to the market significantly. According to ourworldindata.org, as of 1 July 2021, 3.13 billion doses of Covid-19 vaccines had been administered globally. However, high cost of safety hypodermic needles and availability of alternative modes of drug delivery may hamper the market growth over the forecasted period. Moreover, growing awareness in emerging economics will provide lucrative opportunities the market in coming years.

The regional analysis of the global Hypodermic Needles Market is considered for the key regions including Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market due to increased awareness about the importance of hypodermic needles in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027 owing to availability of skilled labour and less stringent wages. India, China and Japan are expected to lead the Asia-Pacific market.
Major market player included in this report are:

Becton, Dickinson and Company
Retractable Technologies, Inc.,
Covidien, Ltd.,
Terumo, Corp.,
Albert David, Ltd.,
Catalent Pharma Solutions,
B-Braun Melsungen AG,
Connecticut Hypodermics, Inc.,
Exel International
MedPro Safety Products, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Safety Hypodermic Needles
Non-Safety Hypodermic Needles
By Application:
Drug Delivery
Vaccination
Blood Specimen Collection
By End User:
Hospitals
Diabetic Patients
Family Practices
Psychiatrics
Others


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Hypodermic Needles Marketin Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors